Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

PBYIPBYI
Showing 8 of 30 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in PUMA BIOTECHNOLOGY INC

NORTHERN TRUST CORP holds 652,386 shares of PBYI (PUMA BIOTECHNOLOGY INC), worth $5.3M as of 2026-Q2. The position was increased (+1.7% shares). PBYI represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$5.3M

Current Shares

652,386

Total Value Change

+$4.5M

Total Shares Change

+334,647

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
652,386
+1.7%
$5.3M0.0%$8.11
27
2026-Q1
Increased
641,753
+4.2%
$4.1M0.0%$6.21
28
2025-Q4
Increased
616,197
+17.0%
$3.7M0.0%$6.01
31
2025-Q3
Increased
526,736
+74.4%
$2.8M0.0%$5.05
40
2025-Q2
Decreased
302,015
-4.9%
$1M0.0%$3.33
0
2025-Q1
Decreased
317,438
-2.5%
$939,6170.0%$3.14
0
2024-Q4
Increased
325,417
+2.4%
$992,5220.0%$3.13
26
2024-Q3
Increased
317,739
+202.4%
$810,2350.0%$2.58
40

Other major holders of PBYI: BLACKROCK ADVISORS LLC, FEDERATED HERMES, INC., BNP PARIBAS FINANCIAL MARKETS, FRED ALGER MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used